| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 29,362 | 19,296 | 14,074 | | Cost of Revenue | 6,777 | 6,160 | 3,615 | | | Gross Profit | 22,585 | 13,136 | 10,459 | | | Operating Expenses | | Research Development | 12,772 | 7,241 | 5,924 | | Selling General and Administrative | 5,933 | 10,173 | 6,360 | | Non Recurring |
-
| (40,170) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,880 | 35,892 | (1,825) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,896 | 2,051 | 948 | | Earnings Before Interest And Taxes | 5,776 | 37,943 | (878) | | Interest Expense | 3 | 9 | 11 | | Income Before Tax | 5,773 | 37,934 | (889) | | Income Tax Expense | 27 | 827 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,746 | 37,107 | (889) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,746 | 37,107 | (889) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,746 | $37,107 | ($889) |
|
1.48% Nasdaq 0.00%
Income Statement
